Asia-Pacific

Scale has become a competitive edge in a rapidly expanding secondaries market.

While a handful of pan-Asian mega-funds are soaking up the majority of LP interest, some argue that local mid-market champions are most likely to deliver outsized returns for investors in Asia-Pacific.

Disclosed healthcare buyout value fell to $51bn in H1 2026 from around $60bn a year earlier, with pressures from AI disruption and the Iran war contributing to the slowdown.

The investment giant is seeking to add relationships in Australia’s mid-market after completing a similar process in Japan, managing director Martin Liew tells PEI.

In today's edition, A $62bn pension is seeking leverage for liquidity; A sovereign wealth fund's PE allocation falls to a nine-year low – with a catch; Chinese PE activity rebounds.

Co-investments and single-asset CVs offer investors 'greater control', partner Zach Jackson tells PEI.

The Indian growth and buyout firm will use some of the proceeds to fund GP commitments in new and existing strategies.

Three-quarters of the asset manager's GP relationships were backed as first-time funds, head of Australia PE Rachael Lockyer tells PEI.